No article text was recorded for this version.
population-specific drug response
Version 2 of 240 papers48 conceptsfrozen 2026-10-04
Papers in this version
- Blog: Pharmacokinetics and bioequivalence study of esomeprazole magnesium enteric-coated tablets 20 mg in healthy Chinese subjects under fasting and fed conditions
- Blog: Comparing efficacy and safety of low-dose versus standard-dose antiplatelet therapy in stroke patients: a meta-analysis
- Blog: Respuesta al Tratamiento con Acetato de Ulipristal en Reducción de Volumen de Miomatosis Uterina de Grandes Elementos
- Blog: CYP2C19 polymorphisms and lipoproteins associated with clopidogrel resistance in children with Kawasaki disease in China: A prospective study
- Blog: Bioequivalence evaluation of generic febuxostat versus Feburic® in healthy Chinese subjects: a randomized crossover study
- Blog: Ticagrelor Versus Clopidogrel in the treatment of Elderly Chinese Chronic Total Occlusion Patients Undergoing Percutaneous Coronary Intervention
- Blog: The Alpha-2A Adrenergic Receptor Gene -1291C/G Single Nucleotide Polymorphism is Associated with the Efficacy of Methylphenidate in Treating Taiwanese Children and Adolescents with Attention-Deficit Hyperactivity Disorder
- Blog: Levodopa/carbidopa/entacapone versus levodopa/benserazide plus pramipexole in Chinese patients with Parkinson’s disease experiencing wearing off
- Blog: A phase 1 study of dalpiciclib, a cyclin-dependent kinase 4/6 inhibitor in Chinese patients with advanced breast cancer
- Blog: Safety and efficacy of a GLP-1 and glucagon receptor dual agonist mazdutide (IBI362) 9 mg and 10 mg in Chinese adults with overweight or obesity: A randomised, placebo-controlled, multiple-ascending-dose phase 1b trial
- Blog: Population Pharmacokinetic Analysis and Model-Based Simulations of Aripiprazole for a 1-Day Initiation Regimen for the Long-Acting Antipsychotic Aripiprazole Lauroxil
- Blog: Asian Society of Gynecologic Oncology International Workshop 2018
- Blog: Pharmacogenomic Diversity among Brazilians: Influence of Ancestry, Self-Reported Color, and Geographical Origin
- Blog: Safety, pharmacokinetics, and efficacy of abexinostat, an novel histone deacetylase inhibitor, in Chinese patients with relapsed/refractory B cell non-Hodgkin lymphoma: a Phase 1 study
- Blog: LDL-cholesterol change and goal attainment following statin intensity titration among Asians in primary care: a retrospective cohort study
- Blog: Capivasertib plus fulvestrant in patients with HR-positive/HER2-negative advanced breast cancer: phase 3 CAPItello-291 study extended Chinese cohort
- Blog: Efficacy of modified Hyper-CVAD regimen on non-Hodgkin's lymphoma and safety evaluation
- Blog: Second-line tislelizumab versus chemotherapy in Japanese patients with advanced or metastatic esophageal squamous cell carcinoma: subgroup analysis from RATIONALE-302
- Blog: Global Pharmacogenomics: Distribution of CYP3A5 Polymorphisms and Phenotypes in the Brazilian Population
- Blog: Angiotensin-Converting Enzyme (ACE) Gene Insertion/Deletion Polymorphism and ACE Inhibitor-Related Cough: A Meta-Analysis
- Blog: Effect of androgen deprivation therapy on cardiovascular function in Chinese patients with advanced prostate cancer: a prospective cohort study
- Blog: Population-specific design of de-immunized protein biotherapeutics
- Blog: Induction of IFN-λ3 as an additional effect of nucleotide, not nucleoside, analogues: a new potential target for HBV infection
- Blog: Phase I Clinical Study of Edaravone in Healthy Chinese Volunteers
- Blog: Clinical outcomes of pharmacological therapies for heart failure in Black vs. White populations: a meta-analysis of randomized controlled trials of heart failure treatment
- Blog: Comparison of pharmacokinetic similarity, immunogenicity, and safety of mepolizumab and BAT2606 in healthy Chinese men in a double-blinded, randomized, single-dose, three-arm parallel-group phase I trial
- Blog: Indirect comparison of novel Oral anticoagulants among Asians with non-Valvular atrial fibrillation in the real world setting: a network meta-analysis
- Blog: Randomized controlled trial of nalfurafine for refractory pruritus in hemodialysis patients
- Blog: Optimising infliximab induction dosing to achieve clinical remission in Chinese patients with Crohn’s disease
- Blog: Geographical distribution of ALDH2 rs671 polymorphism in Chinese angina pectoris patients
- Blog: Intravitreal aflibercept 8 mg in patients from Japan with diabetic macular edema: 48-week subgroup analysis of the PHOTON trial
- Blog: Epidemiology and risk factors associated with gout control among adult Asians: a real-world retrospective cohort study
- Blog: Estimation of median effective doses and 95% effective doses of oliceridine combined with propofol for day-case hysteroscopy under total intravenous anesthesia with preserved spontaneous breathing: an up-and-down sequential allocation trial
- Blog: A randomized, open-label, multi-center, active-controlled phase II study comparing abiraterone acetate tablets (II), an improved formulation, versus originator abiraterone acetate in patients with metastatic castration-resistant prostate cancer
- Blog: A Phase I Dose-Escalation Study of the Pharmacokinetics, Pharmacodynamics, and Safety of a Single Oral Dose of Tigulixostat
- Blog: Phase I clinical trial of NH130 and the prediction of its pharmacokinetics using physiologically based pharmacokinetic modeling
- Blog: PharmaKoVariome database for supporting genetic testing
- Blog: Pharmarcogenetic Mechanism of ACE I/D Polymorphism Adversely Responding to ACE Inhibitors in Regulating the ACE Promoter Activity in Neurons
- Blog: The efficacy and safety of platinum plus gemcitabine (PG) chemotherapy with or without molecular targeted agent (MTA) in first-line treatment of non-small cell lung cancer (NSCLC)
- Blog: Cohort-specific imputation of gene expression improves prediction of warfarin dose for African Americans
History & citation
Current · Permanent link
Cite this direction
Latest version (a living page):
@misc{lacuna_population_specific_drug_response_3f8145d3,
title = {population-specific drug response},
author = {{Lacuna}},
howpublished = {Lacuna research direction},
year = {2026},
url = {https://lacuna.tiptreesystems.com/direction/population-specific-drug-response/rdr_3f8145d361a14b41a2acccd4a7f14c39},
note = {Latest version of a living research direction; cite a version for a fixed text. Accessed 2026-11-21},
}This exact version (version 2, frozen text):
@misc{lacuna_population_specific_drug_response_3f8145d3_v2,
title = {population-specific drug response},
author = {{Lacuna}},
howpublished = {Lacuna research direction},
year = {2026},
url = {https://lacuna.tiptreesystems.com/direction/population-specific-drug-response/rdr_3f8145d361a14b41a2acccd4a7f14c39/v/2},
note = {Version 2, frozen 2026-10-04. Accessed 2026-11-21},
}